Afya (NASDAQ:AFYA) Shares Down 8.7% After Analyst Downgrade

Afya Limited (NASDAQ:AFYAGet Rating)’s stock price traded down 8.7% during mid-day trading on Tuesday after Credit Suisse Group lowered their price target on the stock from $19.00 to $18.00. Credit Suisse Group currently has an outperform rating on the stock. Afya traded as low as $14.31 and last traded at $14.41. 7,738 shares were traded during mid-day trading, a decline of 98% from the average session volume of 459,594 shares. The stock had previously closed at $15.79.

Other equities analysts have also recently issued reports about the company. The Goldman Sachs Group increased their price target on Afya from $12.00 to $13.50 in a report on Tuesday, September 6th. TheStreet raised Afya from a “d+” rating to a “c” rating in a research note on Friday, September 9th.

Hedge Funds Weigh In On Afya

Several hedge funds have recently bought and sold shares of AFYA. Sycomore Asset Management acquired a new stake in Afya in the 1st quarter valued at about $1,122,000. Vontobel Holding Ltd. acquired a new stake in Afya in the 2nd quarter valued at about $345,000. TimesSquare Capital Management LLC raised its position in shares of Afya by 18.9% during the 2nd quarter. TimesSquare Capital Management LLC now owns 1,427,200 shares of the company’s stock worth $14,201,000 after acquiring an additional 227,100 shares in the last quarter. Arisaig Partners Asia Pte Ltd. raised its position in shares of Afya by 293.4% during the 1st quarter. Arisaig Partners Asia Pte Ltd. now owns 556,219 shares of the company’s stock worth $7,799,000 after acquiring an additional 414,822 shares in the last quarter. Finally, Pendal Group Ltd raised its position in shares of Afya by 4.8% during the 3rd quarter. Pendal Group Ltd now owns 960,439 shares of the company’s stock worth $13,024,000 after acquiring an additional 43,651 shares in the last quarter. Institutional investors and hedge funds own 60.45% of the company’s stock.

Afya Stock Down 7.6 %

The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.31 and a current ratio of 1.33. The firm has a market cap of $1.34 billion, a price-to-earnings ratio of 20.84, a price-to-earnings-growth ratio of 0.43 and a beta of 0.88. The firm has a 50-day moving average price of $14.48 and a two-hundred day moving average price of $12.41.

Afya (NASDAQ:AFYAGet Rating) last issued its earnings results on Monday, August 22nd. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.04. Afya had a return on equity of 10.99% and a net margin of 15.67%. The business had revenue of $121.93 million for the quarter, compared to analyst estimates of $119.45 million. On average, sell-side analysts forecast that Afya Limited will post 0.97 earnings per share for the current year.

Afya Company Profile

(Get Rating)

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments.

Featured Stories

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.